NEVNUCLAB
Carson City · Founded 2023
About NEVNUCLAB
At NEVNUCLAB, we are redefining the future of nuclear medicine by accelerating access to next-generation medical isotopes through a scalable, outsourced, and regulation-ready model. Founded in 2023, we partner with leading public labs to identify, produce, and deliver critical isotopes like Actinium-225 and Copper-67 to hospitals, research institutions, and pharmaceutical companies worldwide.
Company Facts
- Founded: 2023
- Legal name: Nevnuclab Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: nevnuclab.com
Canonical: https://fsome.com/organization/nevnuclab-8259692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.